Navigation Links
CooperVision Launches Science and Technology (S&T) Awards Program

PLEASANTON, Calif., May 7, 2013 /PRNewswire/ -- CooperVision is pleased to announce a Science and Technology (S&T) Awards Program. The goal of this awards program is to bring recipients and CooperVision scientists together to explore new areas of technology advancement. The awards program will address ocular surface health and anterior segment symptomology through advancement of technologies including, but not limited to materials, devices and compounds.

"Our goal is to support science and encourage a focus on unmet needs that can be translated back to our community. I am pleased that the CooperVision Science and Technology Awards will provide scientists in academia and research institutes a substantive opportunity to pursue emerging ideas and concepts in a meaningful and focused way," said Arthur Back , Chief Technology Officer for CooperVision.

The CooperVision S&T Awards Program comprises of two awards: The CooperVision Seedling Award and the CooperVision Translational Research Award.

The CooperVision Seedling Award is intended to incentivize collaborations with CooperVision in a new research area for a one year period. This award enables investigators to generate preliminary data that could be used toward a future CooperVision Translational Research Award. Early-career and established faculty in areas other than contact lens research are strongly encouraged to apply. A CooperVision Seedling Award provides funding for one year and is awarded on a one-time basis only. The maximum total cash amount for a CooperVision seedling is $100,000, including indirect costs. 

The CooperVision Translational Research Award is a multi-year award for a substantive translational research project. Early-career and established faculty in areas other than contact lens and research are strongly encouraged to apply. Collaboration between basic scientists, engineers and clinicians are strongly encouraged in order to achieve high-quality, innovative translational research. A CooperVision Translational Research Award provides funding for up to two years, totaling up to $400,000, including indirect costs.  A maximum of $250,000 can be requested for any one year. A CooperVision Translational Research Award may be considered for renewal.

For information of the application process and materials, please visit us at

About CooperVision

CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world's leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges; such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, thereby creating real advantages for customers and wearers. For more information, visit

About The Cooper Companies

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO).  Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value.  Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women.  Headquartered in Pleasanton, CA, Cooper has approximately 7,800 employees with products sold in over 100 countries.  For more information, please visit

SOURCE CooperVision
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CooperVision Renews Its Support of U.S. Military Personnel
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
4. Mylan Launches Generic Version of Zyprexa® Tablets
5. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
6. American Academy of Family Physicians Foundation Launches Cities for Life
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
9. Xtelligent Media Raises $800K in Funding and Launches
10. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
11. Practice Fusion Launches API to Democratize Lab Integrations
Post Your Comments:
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):